Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11957654 Treating benign prostatic hyperplasia

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shahram Shawn Gholami0

John J. Stankus0

Olof Mikael Trollsas0

Date of Patent

April 16, 2024

0

Patent Application Number

180624360

Date Filed

December 6, 2022

0

Patent Citations

US Patent 7906136 Conveniently implantable sustained release drug compositions

0

US Patent 8002745 Retractable syringe with plunger disabling system

0

US Patent 8133491 Compositions and methods for treatment of hyperplastic disorders

0

US Patent 8313763 Sustained delivery formulations of rapamycin compounds

0

US Patent 8362086 Long acting injectable formulations

0

US Patent 8900252 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

0

US Patent 9186464 Dosing injector

0

US Patent 9545464 Syringe with ratcheting operating rod and lockable plunger head

0

...

Patent Primary Examiner

Patrick T. Lewis

0

Patent abstract

Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11957654 Treating benign prostatic hyperplasia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool